Abstract
It has been proposed that there is an increased frequency of glucosidase-β mutations in Lewy body disorders. Our comprehensive DNA sequencing approach found a small number of glucosidase-β mutations in 101 neuropathologically defined Lewy body disease cases (3%) compared to 99 healthy post-mortem controls (1%); odds ratio 3.0 (95% CI: 0.3-29, p = 0.3). All three affected carriers were classified as diffuse Lewy body disease (n = 3/50; 6%). Our study suggests glucosidase-β variants have a limited role in susceptibility to Lewy body disease in North America.
| Original language | English |
|---|---|
| Pages (from-to) | 414-416 |
| Number of pages | 3 |
| Journal | Parkinsonism and Related Disorders |
| Volume | 15 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jul 2009 |
| Externally published | Yes |
ASJC Scopus Subject Areas
- Neurology
- Geriatrics and Gerontology
- Clinical Neurology
Keywords
- Gaucher
- Genetic
- Lewy body
- Parkinson
Fingerprint
Dive into the research topics of 'Glucosidase-beta variations and Lewy body disorders'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS